South and Central America Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and service (Reagents & Consumables, Instruments, and Software & Services), Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), and End User (Independent Reference Laboratories, Hospitals and Transplant Centers, and Others)
The South & Central America human leukocyte antigen (HLA) testing market is expected to grow from US$ 45.71 million in 2022 to US$ 67.38 million by 2028; it is estimated to grow at a CAGR of 6.7% from 2022 to 2028.
Human leukocyte antigens (HLAs) are specialized proteins present on all cell surfaces of the human body except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice area. Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures. Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, driving the HLA testing market.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South & Central America human leukocyte antigen (HLA) testing market at a notable CAGR during the forecast period.
South & Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Table of Contents
South & Central America Human Leukocyte Antigen (HLA) Testing Market Segmentation
The South & Central America human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country. Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the South & Central America human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others. Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others. Based on country, the South & Central America human leukocyte antigen (HLA) testing market is segmented into Brazil, Argentina, and the Rest of South & Central America.
South & Central America Human Leukocyte Antigen (HLA) Testing Market — Companies Mentioned
THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina; Bio-Rad Laboratories, Inc.; F. HOFFMANN-LA ROCHE LTD.; and Takara Bio Inc. are among the major companies operating in the South & Central America human leukocyte antigen (HLA) testing market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Human Leukocyte Antigen (HLA) Testing Market – By Product and Services
1.3.2 South and Central America Human Leukocyte Antigen (HLA) Testing Market – By Technology
1.3.3 South and Central America Human Leukocyte Antigen (HLA) Testing Market – By End User
1.3.4 South and Central America Human Leukocyte Antigen (HLA) Testing Market – By Country
2. South and Central America Human Leukocyte Antigen (HLA) Testing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America Human Leukocyte Antigen (HLA) Testing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America – PEST Analysis
4.3 Expert Opinion
5. South and Central America Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures
5.1.2 Expanding Range of Applications of HLA Testing
5.2 Market Restraints
5.2.1 Errors in Accuracy
5.3 Market Opportunities
5.3.1 Rising Government Funding for Organ Donation
5.4 Future Trends
5.4.1 Technological Advancements in Field of Histocompatibility
5.5 Impact Analysis
6. South and Central America Human Leukocyte Antigen (HLA) Testing Market – Analysis
6.1 South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
7. South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – by Product and Services
7.1 Overview
7.2 South and Central America Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
7.2.1 South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services : South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
8. South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Technology
8.1 Overview
8.2 South and Central America Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
8.2.1 South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
8.2.1.1 South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
8.3 Molecular Assay Technologies
8.3.1 Overview
8.3.2 Molecular Assay Technologies: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 PCR-Based Molecular Assays
8.3.3.1 Overview
8.3.3.2 PCR-Based Molecular Assays: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Sequencing-Based Molecular Assays
8.3.4.1 Overview
8.3.4.2 Sequencing-Based Molecular Assays: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Others
8.3.5.1 Overview
8.3.5.2 Others: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Molecular Assay Technologies
8.4.1 Overview
8.4.2 Non-Molecular Assay Technologies: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9. South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by End User
9.1 Overview
9.2 South and Central America Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)
9.2.1 South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
9.3 Independent Reference Laboratories
9.3.1 Overview
9.3.2 Independent Reference Laboratories: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Hospital & Transplant Centers
9.4.1 Overview
9.4.2 Hospital & Transplant Centers: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10. South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Country
10.1 South and Central America South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market Share, by Country (2022 & 2028) (%)
10.1.2.1 Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2 Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)
10.1.2.1.3 Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3.1 Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.2.1.4 Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2 Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2 Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)
10.1.2.2.3 Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3.1 Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.2.2.4 Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3 Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2 Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)
10.1.2.3.3 Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3.1 Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.2.3.4 Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11. South and Central America Human Leukocyte Antigen (HLA) Testing Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in the South and Central America Human Leukocyte Antigen (HLA) Testing Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 THERMO FISHER SCIENTIFIC INC.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 CareDx
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. HOFFMANN-LA ROCHE LTD.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Takara Bio Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 2. South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 3. South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 4. South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 6. Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 8. Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 10. Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 12. Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 14. Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 16. Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 17. Organic Developments in the South and Central America Human Leukocyte Antigen (HLA) Testing Market
Table 18. Inorganic Developments in the South and Central America Human Leukocyte Antigen (HLA) Testing Market
Table 19. Glossary of Terms, South and Central America Human Leukocyte Antigen (HLA) Testing Market
LIST OF FIGURES
Figure 1. South and Central America Human Leukocyte Antigen (HLA) Testing Market Segmentation
Figure 2. South and Central America Human Leukocyte Antigen (HLA) Testing Market Overview
Figure 3. Reagents And Consumables Held Largest Share of Product Segment in South and Central America Human Leukocyte Antigen (HLA) Testing Market
Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. South & Central America: PEST Analysis
Figure 6. Experts’ Opinion
Figure 7. HLA Testing Market: Impact Analysis of Drivers and Restraints
Figure 8. South and Central America Human Leukocyte Antigen (HLA) Testing Market– Revenue Forecast and Analysis – 2020- 2028
Figure 9. South and Central America Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
Figure 10. Reagents and Consumables: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 11. Instruments: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 12. Software and Services : South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 13. South and Central America Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
Figure 14. Molecular Assay Technologies: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. PCR-Based Molecular Assays: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Sequencing-Based Molecular Assays: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. Non-Molecular Assay Technologies: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. South and Central America Human Leukocyte Antigen (HLA) Testing Market Share, By End User 2022 & 2028 (%)
Figure 20. Independent Reference Laboratories: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Hospital & Transplant Centers: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: South and Central America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. South and Central America South and Central America Human Leukocyte Antigen (HLA) Testing Market Overview, by Country (2022)
Figure 24. South and Central America South and Central America Human Leukocyte Antigen (HLA) Testing Market Share, by Country (2022 & 2028) (%)
Figure 25. Brazil: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Argentina: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of South and Central America: South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Growth Strategies in the South and Central America Human Leukocyte Antigen (HLA) Testing Market (%)
- THERMO FISHER SCIENTIFIC INC.
- CareDx
- QIAGEN
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- F. HOFFMANN-LA ROCHE LTD.
- Takara Bio Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South and Central America Human Leukocyte Antigen (HLA) Testing Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in South and Central America Human Leukocyte Antigen (HLA) Testing Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.